Stable Cell Line: HEP-3B/JAK-Stat Pathway Firefly Luciferase Reporter Quantity: 2 x 10^6 cells Parental Line Details: Hep 3B, a human liver cancer cell line, is derived from a hepatocellular carcinoma. It's widely used in liver cancer, viral hepatitis, and liver-specific gene expression studies, particularly in p53-null systems. Growth Type: Adherent Key Features: Derived from a hepatocellular carcinoma patient with HBV infection and p53-null status, making it ideal for studying p53-independent cancer pathways Target Gene Promoter: JAK-Stat Pathway Activation Responsive Reporter Gene: Firefly Luciferase Selection Marker: Puromycin Safety Level: BSL-2 Shipping: Dry Ice Storage: Liquid Nitrogen